Navigation Links
PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
Date:4/10/2008

BOSTON, April 10 /PRNewswire-FirstCall/ -- Senior experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will discuss best practices for successful partnerships at the 17th Annual Partnerships with CROs conference, to be held April 14-16, 2008 in Las Vegas, Nevada. PAREXEL is an Associate Sponsor of the conference.

PAREXEL experts will present in the following sessions, which address the implementation of metrics to enhance partnership performance, and strategies to successfully leverage emerging markets for global clinical trials:

Monday, April 14

Implementing Performance Metrics to Drive Time, Cost and Quality, and

Enhance Partnership Performance (workshop)

Kate Trainor, Vice President of Integration Services, Perceptive

Informatics, PAREXEL

(9:30 a.m. MT)

Tuesday, April 15

Outsourcing Clinical Trials in Emerging Regions: China

Karen Chu, Executive Director of International Clinical Operations,

PAREXEL APEX

(2:00 p.m. MT)

For more than 25 years, clients worldwide have relied on PAREXEL to provide integrated clinical development, regulatory affairs consulting, and commercialization services, as well as technologies that expedite time-to-market. Attendees at the 17th Annual Partnerships with CROs conference can visit with PAREXEL's Booth #123 in the exhibit hall to discuss these capabilities.

Visitors to PAREXEL's booth will receive a copy of the article "Create a Successful Project Plan for Global Clinical Trials," recently published in Applied Clinical Trials, by Diego Glancszpigel, Vice President of Clinical Operations for Latin America and Graciela Racaro, Senior Director of Clin
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
2. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
3. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
4. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
5. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
6. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
7. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
8. PAREXEL International Announces 2-For-1 Stock Split
9. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
10. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
11. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... MINNEAPOLIS and REHOVOT, Israel , ... UK medical 3D printing specialist, Replica 3DM, supports NHS hospitals ... 3D Printers   - Performing surgery ... and anesthetic times; improves patient recovery and provides an effective ... Stratasys Ltd. (Nasdaq: SSYS ), a ...
(Date:8/26/2014)... , Aug. 26, 2014 Technology ... the symbol (NUUU) has two (2) wholly- owned ... two subsidiaries harness scientifically advanced technology to provide ... NUUU,s Renuell Int,l, Inc. is launching ... skin care products that is made possible because ...
(Date:8/26/2014)... -- Trovagene, Inc. (NASDAQ:  TROV) presented data at ... to the Clinic with an oral presentation ... Tumor DNA in Urine." In this presentation Trovagene ... Monitoring (PCM) platform and results from several studies ... tumor DNA mutations from urine samples of cancer ...
(Date:8/26/2014)... 26, 2014 Albany Molecular Research Inc. (NASDAQ: ... S. Marth , President and Chief Executive Officer at ... Conference on Monday, September 8, 2014 at 8:45 a.m. ... the presentation can be accessed at AMRI,s Investor Relations ... webcast will be archived for 90 days following the ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... CALGARY, April 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") ... his research group at St. James,s University Hospital ... in the April 10 online issue of,Gene Therapy. ... by,Oncolytic Reovirus for the Treatment of Melanoma.", ...
... Technology (NIST), in collaboration with the National Aeronautics ... for making essential measurements on samples of single-walled ... current best practices for characterizing one of the ... generation of nanoscale materials. , The nanotubes are ...
... Inc. (Nasdaq: VION ) today announced that it ... The Nasdaq Capital Market,listing requirements, including the time frame ... announced that it had received a letter, dated,March 24, ... Company,that it does not comply with Marketplace Rule 4310(c ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma 2Carbon nanotube measurements: latest in NIST 'how-to' series 2Vion Pharmaceuticals Files Plan With Nasdaq 2Vion Pharmaceuticals Files Plan With Nasdaq 3
(Date:8/26/2014)... have provided the first evidence that the lack ... early signs of dementia. , Published in ... absence of the protein MK2/3 promotes structural and ... These changes were shown to have a significant ... learning and memory formation capabilities. , An absence ...
(Date:8/26/2014)... consumers, and suppliers has prompted manufacturers to set ... they emit from their smokestacks or discharge into ... environmental performance at every step in their process, ... use and recycling of their products. , This ... as life cycle engineering, which connects the engineers ...
(Date:8/26/2014)... University of Illinois engineers are bringing a ... researchers developed a new continuous glucose monitoring material ... the wavelength shift is so precise that doctors ... for automatic insulin dosing - something not ... , "There are significant limitations to current continuous ...
Breaking Biology News(10 mins):Lack of naturally occuring protein linked to dementia 2Yale journal explores advances in sustainable manufacturing 2A glucose meter of a different color provides continuous monitoring 2A glucose meter of a different color provides continuous monitoring 3
... therapies often succeed at initially eliminating the bulk ... but are eventually thwarted because they cannot eliminate ... cancer stem cells, which ultimately become the source ... by scientists at the University of Pittsburgh School ...
... New research from Colorado State University shows that the ... circadian -- or daily -- rhythms. The study, publishing ... current theory that only 10 percent to 15 percent ... scientists have long known that circadian rhythms regulate the ...
... temples and cultivated for its wood and cottony fibers, ... biologists have clung to for decades: the notion that ... continents were connected 96 million years ago. , Research ... colleagues shows that kapok---and perhaps other rainforest--trees colonized Africa ...
Cached Biology News:Cancer stem cells similar to normal stem cells can thwart anti-cancer agents 2Research finds that circadian rhythms dominate all life functions 2Research finds that circadian rhythms dominate all life functions 3The kapok connection -- Study explains rainforest similarities 2
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
AANAT [Arylalkylamine N-acetyltransferase; EC 2.3.1.87]...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Sheep polyclonal to EBNA 3B ( Abpromise for all tested applications). Antigen: Full length protein....
Biology Products: